JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M002049200 on June 6, 2000

J. Biol. Chem., Vol. 275, Issue 35, 27177-27185, September 1, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/35/27177    most recent
M002049200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Corbett, E. F.
Right arrow Articles by Michalak, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Corbett, E. F.
Right arrow Articles by Michalak, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Conformation of Calreticulin Is Influenced by the Endoplasmic Reticulum Luminal Environment*

Elaine F. CorbettDagger §, Karolina M. MichalakDagger , Kim Oikawa, Steve Johnson||, Iain D. Campbell||, Paul Eggleton||, Cyril Kay, and Marek MichalakDagger **

From the Dagger  Canadian Institutes of Health Research Group in Molecular Biology of Membranes, the  Canadian Institutes of Health Research Group in Protein Structure and Function, Protein Engineering Network of Centers of Excellence and the Department of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada and || Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, OX1 3QU Oxford, United Kingdom

Received for publication, March 13, 2000, and in revised form, May 12, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In order to understand the dynamics of the endoplasmic reticulum (ER) luminal environment, we investigated the role of Ca2+, Zn2+, and ATP on conformational changes of calreticulin. Purified calreticulin was digested with trypsin in the presence or absence of Ca2+, Zn2+, and ATP. At low Ca2+ concentration (<100 µM), calreticulin is rapidly and fully degraded by trypsin, indicating that under these conditions the protein is in a highly trypsin-susceptible conformation. Increasing Ca2+ concentration up to 500 µM or 1 mM resulted in protection of the full-length calreticulin and in generation of the 27-kDa fragment highly resistant to trypsin digestion. The 27-kDa protease-resistant core of the protein represented the NH2-terminal half of calreticulin and was identified by its reactivity with specific antibodies and by NH2-terminal amino acid sequence analysis. Ca2+-dependent changes in calreticulin's sensitivity to proteolysis indicate that agonist-induced fluctuation in the free ER luminal Ca2+ concentration may affect the protein conformation and function. Trypsin digestion of calreticulin in the presence of Zn2+ resulted in the formation of a 17-kDa central protease-resistant core in the protein corresponding to the central region of the protein, indicating that under these conditions the N- and C-domains of the protein are in an extended conformation. Here we also show that calreticulin is an ATP-binding protein but that it does not contain detectable ATPase activity. Digestion of the protein with trypsin in the presence of Mg2+-ATP protects the full-length protein. These results indicate that calreticulin may undergo frequent, ion-induced conformation changes, which may affect its function and its ability to interact with other proteins in the lumen of the ER.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The endoplasmic reticulum (ER)1 plays an essential role in a variety of cellular processes, including the synthesis, post-translational modification, and folding of membrane-associated and secreted proteins (1-6). The lumen of the ER is a dynamic environment perfectly designed for the task of protein folding. It contains a high concentration of Ca2+ binding chaperones and an optimal concentration of ions and nucleotides for protein folding, modification, and assembly.

Several studies have indicated that changes in the concentration of Ca2+ in the ER lumen ([Ca2+]ER) affect many ER functions, including the synthesis, folding, post-translational modification, and secretion of proteins; protein conformation; and chaperone-chaperone or chaperone-substrate interactions (7-15). The ER lumen also contains ATP, which is required to support the correct folding and formation of disulfide bonds in many proteins (16-18). An ATP transporter has been identified in the ER (19, 20), and the ER proteins PDI and BiP are known to bind/utilize ATP in their chaperone action (21-25).

Calreticulin is one of the major Ca2+-binding proteins in the lumen of the ER. The protein can be divided into three main structural regions (26). The highly conserved N-domain binds Zn2+ with high capacity (27), whereas the proline-rich P-domain binds Ca2+ with high affinity (28). The C-domain, which may play a role in the Ca2+ storage function of calreticulin, binds Ca2+ with high capacity (28). In the lumen of the ER, the protein functions as a chaperone and a modulator of Ca2+ homeostasis (26). Calreticulin binds monoglucosylated oligosaccharides (4) and misfolded proteins (29, 30). Importantly, calreticulin responds to fluctuating Ca2+ levels in the lumen of the ER by modulating its ability to interact with other ER proteins and substrates (15). We have suggested that the binding of Ca2+ to the C-domain of calreticulin may allow it to function as a "Ca2+ sensor" for other ER chaperones (15). However, the precise effects of ER constituents such as Ca2+, Zn2+, nucleotides, and other proteins on the structure and function of calreticulin remain to be determined.

In this study, we have investigated the effect of changes in the ER luminal environment (specifically Ca2+, Zn2+, and ATP) on conformational changes in calreticulin. We show that Ca2+, Zn2+, and ATP affect the tertiary structure of calreticulin, as indicated by changes in its sensitivity to protease digestion. Furthermore, we show directly that calreticulin is an ATP-binding protein but does not contain detectable ATPase activity. Our results indicate that dynamic changes within the lumen of the ER can have profound effects on calreticulin's structure, stability, and function.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- ATP-agarose, CL-2B-agarose, bovine IgG, Mg2+-ATP, ADP, AMP, GTP, GDP, trypsin, V8 protease, cathepsin G, and elastase were from Sigma. The Pichia expression system was from Invitrogen. SDS-PAGE reagents and molecular weight markers were from Bio-Rad. Peroxidase-conjugated rabbit anti-goat and goat anti-rabbit IgGs were from Jackson ImmunoResearch Laboratories. The ECL detection kit for Western blotting was from Amersham Pharmacia Biotech. All chemicals were of the highest grade available.

Expression and Purification of Recombinant Calreticulin in Pichia Protein Expression System-- The cDNA of full-length rabbit calreticulin was cloned into pPIC-9 and transformed into the Pichia KM71 strain as recommended by the manufacturer. The expression of calreticulin was induced with 0.5% methanol. The protein was purified by DEAE-Sepharose and Resource Q FPLC column chromatography.2 The NH2-terminal amino acid sequence of full-length calreticulin expressed in Pichia was NH2-EAYVEF1EPVVYFL-, where the underlined residues correspond to the amino acid sequence of mature calreticulin. Biochemical and biophysical analysis of the recombinant calreticulin using mass spectroscopy, CD analysis, disulfide mapping, Ca2+ binding measurements, and antibody reactivity revealed that it was identical to the native, tissue-purified protein.2

Proteolytic Digestions-- Purified, recombinant calreticulin expressed in Pichia was incubated with trypsin at 1:100 (trypsin/protein; w/w) at 37 °C and in the presence or absence of varying concentrations of Ca2+, Zn2+, and Mg-ATP (as indicated in the figure legends). Aliquots were taken at the indicated time points, and the reaction was stopped by the addition of the Laemmli sample buffer (31). Calreticulin (15 µg) was also digested in the absence (5 mM EDTA) or in the presence of Ca2+ (2 mM Ca2+) with elastase, V8 protease, and cathepsin G at a calreticulin/enzyme ratio of 20:1 or 320:1 (w/w) for 2 h at 37 °C at pH 6.4 (elastase) or pH 7.4 (all others). The proteins were separated by 10 or 15% SDS-PAGE (31) and either stained with Coomassie Blue or transferred onto a nitrocellulose membrane (32) and probed with the indicated anti-calreticulin antibodies.

Antibodies-- Goat anti-calreticulin antibodies were extensively characterized (33). This antibody recognizes the C-domain but not the N-domain of calreticulin. Antibodies against the N-terminal synthetic peptide of calreticulin were a generous gift of Dr. K.-H. Krause (University of Geneva). This antibody recognizes the first 12 amino acids of mature calreticulin and has also been extensively characterized (34-36). Antibody binding was detected with appropriate peroxidase-conjugated secondary antibodies diluted 1:10,000, followed by an ECL reaction and exposure to x-ray film. Images of the Coomassie Blue-stained gels and x-ray films were scanned and processed for publication using Adobe Photoshop version 5.5 software.

ATP-Agarose Chromatography-- ATP affinity chromatography was carried out using ATP-agarose and CL-2B-agarose as the control. Calreticulin (5 µg) was incubated at 37 °C for 60 min. with ATP-agarose or CL-2B agarose beads (0.7 g/ml) in a binding buffer containing 10 mM Mops, pH 7.0, 100 mM KCl, 2 mM MgCl2, 0.5 mM EGTA, and 2 mg of bovine IgG (to block nonspecific binding). Beads were then placed in a glass column followed by extensive washing with a binding buffer to remove unbound proteins. ATP bound proteins were eluted with a binding buffer containing 5 mM Mg2+-ATP. Proteins associated nonspecifically with the ATP-agarose were subsequently eluted with 2 M NaCl. Eluted proteins were precipitated with acetone at -20 °C for 16 h, separated on 15% SDS-PAGE, and transferred onto a nitrocellulose membrane. The membranes were probed with anti-calreticulin antibodies as described above.

Circular Dichroism and Equilibrium Sedimentation Measurements-- CD analysis was performed at 25 °C using a Jasco J-720 spectropolarimeter (Jasco Inc., Easton, MD), interfaced to an Epson Equity 386/25 computer and controlled by Jasco software as described previously (15). The instrument was calibrated with ammonium d-(+)-10 camphor sulfonate at 290.5 and 192 nm. Each sample was scanned 10 times, and noise reduction was applied to remove the high frequency before calculating molar ellipticities. The cell path length used was 0.02 cm, and the protein concentration was 0.6 mg/ml in the far ultraviolet. Molar ellipticities were calculated from the equation,


&thgr;=<FR><NU>&thgr;<SUB><UP>obs</UP></SUB></NU><DE>10×l×c</DE></FR> (Eq. 1)
where theta obs is in millidegrees, l represents the path length in cm, and c represents the concentration in mol/liter × number of amino acids in the sequence. The unit for molar ellipticity is degree cm2/dmol. The CD spectra were analyzed for secondary structure elements by the Contin ridge regression analysis program of Provencher and Glöckner (37).

Sedimentation Velocity Measurements-- Sedimentation velocity experiments were carried out at 20 °C and 50,000 rpm using the XLI Analytical Ultracentrifuge and Interference optic following the procedures outlined in the instruction manual (Spinco Business Center of Beckman Instruments, Inc. Palo Alto, CA). 400 µl of sample solution and 400 µl of dialysate were loaded into two sector CFE centerpiece sample cells containing sapphire windows. Runs were performed for 4 h, during which a minimum of 30 scans were taken. The sedimentation velocity data were analyzed using the Second Moment Method contained in the Beckman Analysis Program (Optima XL-A/XL-I Data Analysis Software, version 4.0; Spinco Business Center of Beckman Instruments, Inc.) to determine the sedimentation coefficient from the following relationship,


Sϖ<SUP>2</SUP>=<FR><NU>dlnr</NU><DE>dt</DE></FR> (Eq. 2)
where S represents the observed sedimentation coefficient; pi  represents angular velocity; r represents radial position of the solvent/protein boundary; and t represents the time in seconds. By measuring the movement of the boundary over time and plotting ln r versus pi 2t, a straight line should be obtained with the slope = S.

The program Sednterp (Sedimentation Interpretation Program, version 1.01, created by David B. Haynes (Magdelan College), Tom Laue (University of New Hampshire), and John Philo (Amgen)) was then used to calculate S20,w according to the following relationship,
S<SUB>20, w</SUB>=<UP>s</UP><FENCE><FR><NU>&eegr;<SUB>t</SUB></NU><DE>&eegr;<SUB>20</SUB></DE></FR></FENCE><FENCE><FR><NU>&eegr;<SUB>sol</SUB></NU><DE>&eegr;<SUB>w</SUB></DE></FR></FENCE><FENCE><FR><NU>1−&ngr;&rgr;<SUB>20, w</SUB></NU><DE>1−&ngr;&rgr;<SUB>t, sol</SUB></DE></FR></FENCE> (Eq. 3)
where S20,w represents the sedimentation coefficient corrected to water at 20 °C; s represents the observed sedimentation coefficient; eta t represents the viscosity of water at run temperature; eta 20 represents the viscosity of water at 20 °C; eta sol represents the viscosity of sample solution at known temperature t'; eta w represents the viscosity of water at t' degrees; rho 20,w represents the density of water at 20 °C; rho t, sol represents the density of sample solution at run temperature; and nu  represents the partial volume of the solute.

Miscellaneous Methods-- ATP hydrolysis was carried out using a coupled enzyme system (38). Protein concentration was determined by the procedure of Bradford (39). NH2-terminal sequence analysis of native and recombinant proteins was carried out on samples, which were electroblotted to Immobilon (polyvinylidene difluoride) membranes (40). Free Ca2+ concentrations were calculated using Max Chelator, Winmaxc version 1.70.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ca2+-dependent Conformation Changes in Calreticulin-- In response to agonist stimulation of cells, the [Ca2+]ER undergoes dynamic changes (41). In a steady-state situation, the [Ca2+]ER is in excess of 400 µM. After agonist-evoked Ca2+ release from the ER, the [Ca2+]ER is reduced to <50 µM (42). Therefore, upon agonist stimulation, Ca2+-binding proteins in the lumen of the ER, including calreticulin, experience frequent changes in Ca2+ concentration. To evaluate the importance of [Ca2+]ER in calreticulin's function, we investigated the effect of Ca2+ on calreticulin's sensitivity to protease digestion. Large quantities of calreticulin were expressed in Pichia and purified.2 The purified protein was digested with trypsin (1:100, trypsin/calreticulin) over a range of physiologically relevant Ca2+ concentrations, from low (0-100 µM, representing empty Ca2+ stores) to high (500-1000 µM, representing full Ca2+ stores) (41). Fig. 1 shows that in the absence of Ca2+ (A) or in the presence of 100 µM Ca2+ (B) calreticulin was almost completely degraded by trypsin within 2 min of incubation. This indicates that at low concentrations of Ca2+ calreticulin was highly susceptible to digestion by trypsin. In contrast, at Ca2+ concentrations of 500 µM (C) or 1 mM (D) calreticulin exhibited resistance to trypsin digestion, and when digestion occurred it resulted in the generation of a 27-kDa protein, which was highly resistant to further trypsin digestion (Fig. 1, C and D). At high Ca2+ concentration, the proteolytic activity of trypsin is highly increased (43, 44), yet the 27-kDa fragment was extremely resistant to trypsin digestion. Indeed, in the presence of 1 mM Ca2+, the 27-kDa fragment was resistant to trypsin digestion for a period greater than 6 h at 37 °C (not shown). Similar results were obtained when calreticulin was digested with elastase, V8 protease, and cathepsin G (Fig. 2).


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 1.   Trypsin digestion of calreticulin. Purified calreticulin was incubated with trypsin at 1:100 (trypsin/protein; w/w) at 37 °C and in the presence or absence of a varying concentration of Ca2+ as indicated. Aliquots were taken at the time points indicated, and the proteins were separated by SDS-PAGE and stained with Coomassie Blue as described under "Experimental Procedures." The arrow indicates the 27-kDa protease-resistant fragment of calreticulin. The positions of Bio-Rad molecular weight marker proteins are indicated.


View larger version (72K):
[in this window]
[in a new window]
 
Fig. 2.   Protease digestion of calreticulin. Purified calreticulin (lane 1) was digested with V8 protease (A), elastase (B), and cathepsin G (C) as described under "Experimental Procedures." Digestion was carried out in the presence of 5 mM EDTA or in the presence of 2 mM Ca2+. Lane 2, digestion in the presence of 2 mM Ca2+ at a calreticulin/enzyme ratio of 320:1 (w/w); lane 3, digestion in the presence of 5 mM EDTA at a calreticulin/enzyme ratio of 320:1 (w/w); lane 4, digestion in the presence of 2 mM Ca2+ at a calreticulin/enzyme ratio of 20:1 (w/w); lane 5, digestion in the presence of 5 mM EDTA at a calreticulin/enzyme ratio of 20:1 (w/w). The arrow indicates the 27-kDa protease-resistant fragment of calreticulin. The positions of the molecular weight marker proteins are indicated.

To identify the Ca2+-sensitive, trypsin-resistant 27-kDa proteolytic fragment of calreticulin, we carried out immunological analysis and NH2-terminal amino acid sequence analysis. Calreticulin was digested with trypsin in the presence of 1 mM Ca2+ followed by Western blot analysis. First, we used a rabbit anti-synthetic peptide antibody, which recognizes the first 12 amino acids of mature calreticulin (34, 35). Fig. 3A shows that these antibodies reacted with full-length calreticulin, as expected, and with the 27-kDa tryptic fragment of the protein. This indicates that proteolysis proceeded from the C-terminal region of the protein, leaving the amino-terminal region intact. Next, we used a goat anti-calreticulin antibody, which recognizes the C-domain of calreticulin (28). As expected, this antibody recognized the full-length protein (Fig. 3B). However, the 27-kDa fragment was not recognized by this antibody (Fig. 3B), indicating that it did not include the C-domain of the protein. A short, C-domain fragment of calreticulin (~17-kDa) was detected by the goat antibody during the first 5 min of tryptic digestion, but this fragment was completely digested after 10 min of incubation with trypsin (Fig. 3B). The identity of the trypsin-resistant 27-kDa fragment was further confirmed by NH2-terminal amino acid sequence analysis. The amino acid sequence we obtained (NH2-EAYVEF1EPVVYFKEQF-) corresponded to the NH2-terminal amino acid sequence of full-length recombinant calreticulin expressed in Pichia. Identical NH3-terminal amino acid sequence (NH2-EAYVEF1EPVVYFKEQF-) was also obtained for a 27-kDa fragment generated with elastase, V8 protease, or cathepsin (Fig. 2), indicating that it was identical to the 27-kDa fragment generated with trypsin.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Immunological identification of protease-resistant fragment of calreticulin. Purified calreticulin was digested with trypsin (1:100; trypsin/protein; w/w) in the presence of 1 mM Ca2+ for the time indicated. Proteins were separated by SDS-PAGE, transferred to nitrocelluose membrane, and probed with antibodies against the N terminus of calreticulin (A) or the C terminus of the protein (B). The arrow indicates the 27-kDa protease-resistant fragment. The positions of Bio-Rad molecular weight marker proteins are indicated.

These results indicate that calreticulin's susceptibility to tryptic digestion, particularly in the NH2-terminal region, is altered by the binding of Ca2+. This probably results from Ca2+-dependent conformational changes in the protein. It appears that at Ca2+ concentrations approximating those in full ER Ca2+ stores, the N-domain and P-domain region of calreticulin form a 27-kDa, protease-resistant core (Fig. 3). Under these conditions, the C-domain of the protein is in an extended conformation, hence accessible to digestion with the protease.

Zn2+-dependent Conformational Changes in Calreticulin-- Zn2+ plays an important regulatory role in intracellular signal transduction, and it is an important structural and functional element of many proteins including calreticulin (45). Zn2+ binds to the N-domain of calreticulin, affecting its interaction with other proteins and inducing conformational changes, as determined by CD spectra analysis (15, 46). Therefore, we examined the effect of Zn2+ on calreticulin's protease resistance. Calreticulin was digested in the presence of 200 µM Zn2+, a concentration that also produces the largest conformational change in the protein (15, 46).

Fig. 4 shows that during the first 10 min of trypsin digestion, in the presence of 200 µM Zn2+, two major proteolytic fragments were generated. One was a 48-kDa fragment that reacted with anti-N-terminal calreticulin antibodies, and the other was a 19-kDa fragment that did not react (data not shown). During prolonged digestion, the 48-kDa fragment disappeared, and the 19-kDa fragment was digested further, with the removal of an additional 40-50 NH2-terminal residues, producing a 17-kDa trypsin-resistant fragment (Fig. 4, 90-180 min). Neither the 19-kDa nor the 17-kDa fragment reacted with antibodies against the N- and C-terminal regions of calreticulin, suggesting that they represented an internal region of the protein. Amino acid sequence analysis of each fragment revealed two NH2-terminal sequences, indicating that they are actually doublets. The N-terminal amino acid sequences of the 19-kDa fragments were NH2-71GQPL- and NH2-78TVKHEQNI-. The N-terminal amino acid sequences of the 17-kDa fragments were NH2-118DSXYXIM- and NH2-158IVRP-. Zn2+ has been reported to have either no effect on trypsin activity (47) or to increase its proteolytic activity (43, 44), yet a 17-kDa fragment was relatively resistant to trypsin digestion in the presence of 200 µM Zn2+.


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 4.   Zn2+-dependent proteolysis of calreticulin. Purified calreticulin was incubated with trypsin (1:100; trypsin/protein; w/w) at 37 °C in the presence of 200 µM Zn2+. Digestion was stopped at time points indicated, and the proteins were separated by SDS-PAGE followed by staining with Coomassie Blue as described under "Experimental Procedures." The arrows indicate the positions of 48-, 19-, and 17-kDa protease-resistant fragments of calreticulin. The positions of Bio-Rad molecular weight marker proteins are indicated.

Previous studies have shown that Zn2+ binding to calreticulin induces conformational changes in the protein (15, 46). Here we show that these changes lead to the formation of a central, protease-resistant core, which encompasses most of the P-domain of calreticulin. At the same time, the N terminus and C terminus of calreticulin may be in an extended conformation, which would explain their accessibility to digestion by the protease (Fig. 4). Trypsin digestion of calreticulin in the presence of both 1 mM Ca2+ and 100 µM Zn2+ resulted in the generation of proteolytic fragments identical to those observed in the presence of 200 µM Zn2+ alone (data not shown).

ATP-dependent Conformational Changes in Calreticulin-- Protein folding in the lumen of the ER requires ATP (16-18). In order to investigate possible roles for ATP in the function of calreticulin, we carried out limited proteolytic digestion of calreticulin in the presence and absence of Mg2+-ATP. Mg2+ and ATP have no effect on trypsin proteolytic activity (44, 48). Fig. 5 shows that in the presence of 1 mM Mg2+-ATP full-length calreticulin was quite resistant to trypsin digestion and was protected for the first 45 min of incubation. The identity of the "protected" full-length calreticulin was confirmed by NH2-terminal amino acid sequence analysis (data not shown). Mg2+ alone had no protective effect (data not shown). ADP, AMP, GTP, and GDP also did not have any protective effect (data not shown), indicating that they did not bind to calreticulin. After 5 min of incubation with trypsin, in addition to the full-length protein, a 30-kDa major proteolytic fragment was observed (Fig. 5B). The 30-kDa fragment was rapidly digested to small peptides. It appears that calreticulin binds Mg2+-ATP and that this significantly reduces its susceptibility to proteolytic digestion, probably via a conformational change. A striking difference in the protective effects of Ca2+, Zn2+, and ATP against tryptic digestion of calreticulin is that only ATP protected the C-domain of the protein.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 5.   ATP-dependent proteolysis of calreticulin. Purified calreticulin was incubated with trypsin (1:100; trypsin/protein; w/w) at 37 °C in the presence or absence of 1 mM Mg2+-ATP. Digestion was stopped at the time points indicated, and the proteins were separated by SDS-PAGE and stained with Coomassie Blue as described under "Experimental Procedures." The arrow indicates the position of full-length calreticulin (60-kDa). The positions of Bio-Rad molecular weight marker proteins are indicated.

Next, to mimic a more physiological environment, we investigated the combined effect of Ca2+, Zn2+, and Mg2+-ATP on calreticulin's sensitivity to trypsin. Fig. 6 shows the effect of ATP on the conformation of calreticulin, in the presence of 200 µM Zn2+ (A) or 1 mM Ca2+ (B). In the presence of Zn2+ and Mg2+-ATP, the digestion of calreticulin by trypsin produced a 55-kDa trypsin-resistant fragment (Fig. 6A). Under these conditions, the full-length calreticulin also showed significant resistance (more than 2 h) to proteolysis. The NH2-terminal amino acid sequence of the 55-kDa fragment was NH2-78TVKHEQNID-, which is identical to the NH2-terminal amino acid sequence of the 19-kDa tryptic fragment produced in the presence of Zn2+ alone (Fig. 4). The difference between these two fragments was that the 19-kDa fragment was missing the C-domain of calreticulin. This supports our previous observation that Mg2+-ATP protects the C-domain of calreticulin from tryptic digestion.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 6.   Proteolysis of calreticulin. Purified calreticulin was incubated with trypsin (1:100; trypsin/protein; w/w) at 37 °C in the presence of 1 mM Mg2+-ATP and 200 µM Zn2+ (A) or in the presence of 1 mM Mg2+-ATP and 1 mM Ca2+ (B). The proteins were separated by SDS-PAGE and stained with Coomassie Blue. The arrows indicate the positions of full-length calreticulin (60 kDa) and 58-, 55-, and 27-kDa protease-resistant fragments of the protein. The positions of Bio-Rad molecular weight marker proteins are indicated.

Fig. 6B shows that tryptic digestion of calreticulin in the presence of Mg2+-ATP and Ca2+ resulted in the generation of three major fragments, one 58, one 55, and one 27 kDa. The NH2-terminal amino acid sequence of the 58-kDa fragment was NH2-EAYVEF1EPVVYFK-, and it corresponded to a full-length recombinant calreticulin. This indicated that under these conditions proteolysis of calreticulin proceeded from the C-terminal region of the protein. The NH2-terminal amino acid sequence of the 27-kDa fragment was also NH2-EAYVEF1EPVVYFKEQF-. This sequence, which corresponds to the amino-terminal sequence of full-length, mature calreticulin, is identical to the NH2-terminal amino acid sequence of the 27-kDa trypsin-resistant fragment obtained in the presence of 500 µM Ca2+ (Figs. 1-3). The 27-kDa tryptic fragment obtained in the presence of Mg2+-ATP and Ca2+, as expected, interacted with the anti-N-terminal antibody but not with the anti-C-terminal antibody (data not shown).

Biophysical Analysis of ATP-dependent Conformational Changes in Calreticulin-- To examine ATP-dependent conformational changes in calreticulin, far UV CD analysis of the protein was carried out in the absence and presence of Mg2+-ATP, Mg2+-ATP plus Zn2+, Mg2+-ATP plus Ca2+, and Mg2+-ATP plus Ca2+ and Zn2+. Control experiments were carried out in the absence and presence of 1 mM Ca2+, 1 mM Zn2+, and 1 mM Mg2+. The CD spectra were analyzed for secondary structural elements by the Contin ridge regression analysis program (37), and representative data are shown Table I. The apoprotein has ~10% alpha -helix and 66% beta -sheet-beta -turn, similar to values published earlier (15). The addition of Mg2+-ATP alone and of Mg2+-ATP with Zn2+ and/or Ca2+, resulted in small (just outwith experimental error) changes in secondary structural elements. Since CD changes are averaged over the entire molecule, they are often not a very sensitive measure of small conformational changes.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Provencher-Glöckner secondary structural analysis of calreticulin (CRT) in the absence and presence of Mg2+-ATP and metals
Measurements were carried out in the presence of a buffer containing 25 mM PIPES, pH 6.8, 100 mM NaCl, 1 mM dithiothreitol, 1 mM EGTA. The Zn2+ and Ca2+ concentrations given are the free amount in the solution.

The binding of ATP to calnexin causes its ER luminal region to dimerize (49). Therefore, we used sedimentation velocity analysis to explore possible effects of ATP on the oligomerization of calreticulin. Table II indicates that S20,w values of calreticulin, at a concentration of 3.07 mg/ml, are indistinguishable under all conditions examined. Apparently, the binding of ATP to calreticulin does not induce it to form oligomers.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Sedimentation velocity of calreticulin (CRT) in the absence and presence of ATP and metals

Calreticulin Binds ATP-- ATP-dependent conformational changes in calreticulin, as measured by its altered sensitivity to proteolysis, suggest that the protein binds ATP. In order to demonstrate directly that calreticulin binds ATP, we carried out ATP affinity chromatography of the purified protein (Fig. 7A). CL-2B agarose chromatography of the protein was carried out as a control (Fig. 7B). Calreticulin was applied to the column. This was followed by extensive washing with the binding buffer and then elution of ATP binding proteins with 5 mM ATP. Importantly, a significant amount of calreticulin was bound to the ATP-agarose and was specifically eluted with 5 mM ATP (Fig. 7A, 5 mM ATP lane). In contrast, calreticulin did not bind to the CL-2B agarose control column (Fig. 7B). Subsequent application of 2 M NaCl eluted no further calreticulin, indicating that all calreticulin bound to the column had been eluted by the ATP (Fig. 7A, 2 M NaCl lane). These experiments demonstrate that calreticulin binds ATP.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 7.   Direct binding of ATP to calreticulin. Calreticulin was incubated at 37 °C with ATP-agarose or control agarose (CL-2B Agarose) beads in a binding buffer as described under "Experimental Procedures." ATP-bound proteins were eluted with a binding buffer containing 5 mM Mg2+-ATP (5 mM ATP lane) followed by a wash with 2 M NaCl (M NaCl lane). Eluted proteins were separated on SDS-PAGE and transferred onto nitrocellulose membrane. Membranes were probed with anti-C terminus calreticulin antibodies as described under "Experimental Procedures." The positions of Bio-Rad molecular weight marker proteins are indicated. CRT, calreticulin.

Chaperones localized in the lumen of the ER are also known to hydrolyze ATP (21-25). Therefore, we tested calreticulin's ability to hydrolyze ATP, in the presence and absence of 100 µM and 1 mM Ca2+, using a coupled enzyme system (38). Microsomal vesicles isolated from HEK293 cells were used as a control (Table III) (38). We found that calreticulin did not hydrolyze ATP under these conditions (Table III).

                              
View this table:
[in this window]
[in a new window]
 
Table III
ATP hydrolysis by calreticulin
ATPase activity of calreticulin and microsomal vesicles isolated from HEK293 cells was measured as described under "Experimental Procedures" (38). Data are means ± S.E. of three independent experiments. ND, not detectable.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this study, we show that environmental conditions in the lumen of the ER can affect calreticulin's conformation as documented by its sensitivity to proteolytic with trypsin, elastase, V8 protease, and cathepsin G. Specifically, the binding of Ca2+, Zn2+, and Mg2+-ATP to calreticulin appears to induce conformational changes in the protein, which lead to the formation of a protease-resistant core structure. The protease-resistant core always encompasses the P-domain of the protein. Ca2+ binding protects the N-terminal (N-domain and P-domain) region of calreticulin, Zn2+ protects its P-domain, and Mg2+-ATP protects the full-length protein. These results suggest that the N- and C-domains of calreticulin are flexible and may undergo frequent, ion-induced changes in conformation. These conformational changes may explain how Ca2+ and Zn2+ may alter the function of calreticulin. In this study, we also show that calreticulin binds ATP. Despite this, the protein does not hydrolyze Mg2+-ATP, and ATP does not induce formation of calreticulin oligomers. We conclude that changes in the concentration of Ca2+, Zn2+, and Mg2+-ATP in the lumen of the ER significantly affect the conformation, stability, and function of ER luminal chaperones.

ATP is required to support correct folding and correct disulfide bond formation in many proteins, and it is an important component of the ER luminal environment (16-20). For example, ATP is required in the lumen of the ER for protein phosphorylation (50-57), protein degradation (58), and protein folding and post-translational modification (16, 17, 22-25). Many chaperones residing in the ER bind and use ATP. For example, BiP and PDI both bind and hydrolyze ATP (21-25). Grp94 also binds ATP (19), although neither ATP binding nor hydrolysis is essential for its peptide binding activity (59). Calreticulin and other ER chaperones (Grp170, PDI, BiP, ERp72, and Grp94) form Ca2+-dependent and ATP-sensitive complexes with misfolded proteins (60, 61). Here we provide the first direct evidence that calreticulin binds ATP, although we found no evidence that it hydrolyzes the ATP. We also show that ATP significantly reduces calreticulin's susceptibility to tryptic digestion, indicating that ATP stabilizes specific conformation of the protein. Importantly, calreticulin does not bind GTP, GDP, ADP, and AMP as determined by its sensitivity to proteolysis.

Fig. 8 shows a proposed model for conformational changes of calreticulin in the ER lumen. The most distinctive feature of ATP binding to calreticulin is that it protected the full-length protein from tryptic digestion (Fig. 8, 1). This is in contrast to Ca2+ and Zn2+. For example, Ca2+ binding to the low affinity and high capacity C-domain results in conformational changes in the C-terminal region of calreticulin, making it susceptible to proteolysis (Fig. 8, 2 and 3). In the presence of Zn2+, the N- and C-domain regions of calreticulin also appear to take an extended conformation that is susceptible to proteolysis (Fig. 8, 2). While there is no obvious nucleotide-binding site in calreticulin, the protection of the C-domain by ATP is suggestive that its binding involves the C-domain. This is further supported by the ATP-dependent protection of the C-domain in the presence of Zn2+ (Fig. 8, 4). On the other hand, ATP has less effect on the C-domain of calreticulin in the presence of Ca2+ (Fig. 8, 5), indicating that Ca2+ may compete with ATP for binding to the C-domain. ATP binding could play a role in protection of this region of the protein or in regulation of its activity. Furthermore, ATP causes a slight enhancement in oligosaccharide binding to the P-domain of calreticulin, whereas Ca2+ enhances this binding significantly (14). Ca2+- and ATP-dependent conformational changes of calreticulin described here may play an important role in the regulation of this chaperone function of calreticulin. Recently, Saito et al. (29) reported that ATP affects interaction between calreticulin and misfolded proteins. Via these interactions, the chaperone activity of calreticulin may be modified or controlled by changes in the concentration of Ca2+ and ATP in the lumen of the ER. Other recent observations support this suggestion. Similarly, ATP-induced conformational changes in BiP, another ER chaperone, are necessary for it to release bound peptide (23, 24). ATP binding to calreticulin results in dramatic changes in the structure of the protein (Fig. 8, 1), and it may play a role in the regulation of calreticulin chaperone activity by increasing its surface hydrophobicity and enhancing its ability to suppress aggregation of both glycosylated and nonglycosylated unfolded proteins.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 8.   A hypothetical model of protease sensitivity of calreticulin. 1, effects of ATP on the proteolysis of calreticulin. In the presence of ATP, full-length calreticulin is resistant to digestion with trypsin. Ca2+ binding to the C-domain of calreticulin in the presence of ATP (5) results in conformational changes in the protein, leading to unmasking of the C-domain of the protein. 4 shows that in the presence of ATP and Zn2+, the N-domain of the protein is an extended conformation. 2, Zn2+ binding to the N-domain of calreticulin results in a conformational change, leading to unmasking of the N- and C-domains of the protein and to the formation of a protease-resistant core consisting of the P-domain and a part of the N-domain of the protein. Ca2+ binding to the C-domain of calreticulin (3) induces conformational change, resulting in proteolysis of the C-domain and formation of a protease-resistant core encompassing the N- and P-domains of the protein.

Mg2+-ATP binds to calnexin, induces protein oligomerization, and increases calnexin's sensitivity to proteolysis (49). In contrast, we found that ATP binding to calreticulin does not promote its oligomerization; however, it protects calreticulin from proteolysis. These findings indicate that, while ATP may play an important role in both proteins, its effects are significantly different. Importantly, calreticulin and calnexin interact with very different substrates, and the effects of ATP and Ca2+ may be responsible for these differences.

Calreticulin binds Zn2+, and Zn2+ is found in intracellular compartments known to contain calreticulin such as the ER, sarcoplasmic reticulum, synaptic vesicles, and secretory granules (62-65). This binding involves highly conserved histidine residues in the N-domain of the protein (27), and it induces conformational changes as measured by CD spectroscopy and fluorescence techniques (15, 27, 29). Zn2+ also affects interactions between calreticulin and other ER chaperones and between calreticulin and misfolded proteins (15, 27, 29). In this study, we show that Zn2+-dependent conformational changes in calreticulin result in the formation of a protease-resistant central core (Fig. 8, 2). The N-domain and the C-domain of the protein are unprotected and therefore may be in an extended conformation (Fig. 8, 2). A recent study reports that Zn2+ enhances calreticulin's ability to reduce the aggregation of newly synthesized proteins (29). The N- and C-domains of calreticulin may be involved in this, via interaction with misfolded proteins (not glycoproteins) (Fig. 8, 2). Indeed, CD spectra analysis shows that Zn2+ binding increases the hydrophobicity of calreticulin, which could enhance its interaction with hydrophobic regions of misfolded proteins.

The ER is one of the most important sources of intracellular Ca2+. Although much Ca2+ in the lumen of the ER is stored by binding to chaperones, a significant portion of the Ca2+ is free (41). In response to external stimuli, the concentration of this Ca2+ (free [Ca2+]ER) fluctuates (41, 42). The free [Ca2+]ER changes from as high as 500 µM to as low as 1 µM (42). In this study, we have shown for the first time that Ca2+ binding also alters calreticulin's conformation as monitored by its susceptibility to tryptic digestion. At low Ca2+ concentrations (>100 µM, empty Ca2+ stores), Ca2+ binds only to high affinity sites located in the P-domain of calreticulin (28). Under these conditions, calreticulin appears to exist in a conformation that is "relaxed" (exposed and highly susceptible to proteolysis). When the concentration of Ca2+ is increased to >500 µM (corresponding to full Ca2+ stores) Ca2+ also binds to the C-domain of calreticulin. When this happens, the protein appears to undergo a conformational change, forming a core that is protease-resistant and that encompasses the highly conserved N-domain and the lectin-like P-domain of calreticulin, while the C-domain is in an extended conformation able to bind Ca2+ (Fig. 8, 3). Most importantly, it is low affinity Ca2+ binding in the C-domain that is responsible for these changes and not high affinity binding in the P-domain. It is likely that these Ca2+-induced conformational changes in calreticulin are responsible for the Ca2+-dependent interaction of calreticulin with PDI and ERp57 (Fig. 8, 3) (15, 46). Furthermore, Ca2+ binding to the ER luminal region of calnexin induces conformational changes in calnexin as measured by its resistance to proteinase K digestion (49). Chaperone function of both calreticulin and the ER luminal region of calnexin may be regulated by Ca2+-dependent changes in their conformation. Our results also indicate that the [Ca2+]ER can significantly affect the conformation and stability of calreticulin. For example, the degradation of both PDI and calreticulin by ERp72 is Ca2+-dependent (66). Specifically, the degradation of PDI is enhanced at 1 mM Ca2+, whereas the degradation of calreticulin is inhibited (66).

The formation of the Ca2+-dependent protease-resistant 27-kDa fragment of calreticulin may have important physiological and pathophysiological implications. For example, autoantibodies against calreticulin are present in the sera of a number of autoimmune conditions (67). The NH2-terminal region of calreticulin, corresponding to the Ca2+-resistant 27-kDa fragment, contains most of the antigenic sites (68). The same protease-resistant fragment of calreticulin is produced in the VERO76 cells infected with a wild type Rubella virus.3 It is tempting to speculate that viral infection or other cellular stresses may induce release of calreticulin and expose the protein to proteolytic enzymes in the presence of high Ca2+ concentration. This would result in the production of high levels of protease-resistant calreticulin fragment with a highly antigenic conformation. A similar NH2-terminal fragment of calreticulin has been isolated from an Epstein-Barr virus-immortalized cell line and shown to inhibit angiogenesis and endothelial cell proliferation (69). In this study, conformational changes in the ER chaperone calreticulin have been defined in the presence of Ca2+, Zn2+, and ATP. It will be important to determine precisely how such conformational changes regulate the physiological function of the protein intracellularly. Moreover, proteolytic fragments of calreticulin released from cells undergoing stress have been observed to interact with proteins and cells of the immune system. Knowledge of these events will also help us understand the pathological significance of calreticulin released into the extracellular environment.

    ACKNOWLEDGEMENT

The superb technical assistance of Monika Dabrowska is greatly appreciated.

    FOOTNOTES

* This work was supported by grants from the Canadian Institutes of Health Research and from the Heart and Stroke Foundations of Alberta (to M. M.), a grant from the Protein Engineering Network of Centers of Excellence (to C. M. K.), and Arthritis Research Campaign Grant E0521 (to P. E.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Recipient of a studentship from the Alberta Heritage Foundation for Medical Research and from the Heart and Stroke Foundation of Canada.

** Canadian Institutes of Health Research Senior Scientist and Medical Scientist of the Alberta Heritage Foundation for Medical Research. To whom correspondence should be addressed: CIHR Group in Molecular Biology of Membranes, Dept. of Biochemistry, University of Alberta, Edmonton, Alberta T6G 2H7, Canada. Tel.: 780-492-2256; Fax: 780-492-0886; E-mail: marek.michalak@ualberta.ca.

Published, JBC Papers in Press, June 6, 2000, DOI 10.1074/jbc.M002049200

2 Andrin, C., Corbett, E. F., Johnson, S., Dabrowska, M., Campbell, I. D., Eggleton, P., Opas, M., and Michalak, M. (2000) Protein Purif. Exp., in press.

3 H. Nakhasi, personal communication.

    ABBREVIATIONS

The abbreviations used are: ER, endoplasmic reticulum; [Ca2+]ER, ER lumen Ca2+ concentration; PDI, protein-disulfide isomerase; PAGE, polyacrylamide gel electrophoresis; Mops, 4-morpholinepropanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Gething, M. J., and Sambrook, J. (1992) Nature 355, 33-45
2. Bergeron, J. J. M., Brenner, M. B., Thomas, D. Y., and Williams, D. B. (1994) Trends. Biochem. Sci. 19, 124-128
3. Williams, D. B. (1995) Biochem. Cell Biol. 73, 123-132
4. Trombetta, E. S., and Helenius, A. (1998) Curr. Opin. Struct. Biol. 8, 587-592
5. Ferrari, D. M., and Söling, H.-D. (1999) Biochem. J. 339, 1-10
6. Ellgaard, L., Molinari, M., and Helenius, A. (1999) Science 286, 1882-1888
7. Booth, C., and Koch, G. E. L. (1989) Cell 59, 729-737
8. Sambrook, J. F. (1990) Cell 61, 197-199
9. Lodish, H. F., and Kong, N. (1990) J. Biol. Chem. 265, 10893-10899
10. Lodish, H. F., Kong, N., and Wikstrom, L. (1992) J. Biol. Chem. 267, 12753-12760
11. Baksh, S., Burns, K., Andrin, C., and Michalak, M. (1995) J. Biol. Chem. 270, 31338-31344
12. Meldolesi, J., and Pozzan, T. (1998) J. Cell Biol. 142, 1395-1398
13. Meldolesi, J. (1998) Nature 392, 863
14. Vassilakos, A., Michalak, M., Lehrman, M. A., and Williams, D. B. (1998) Biochemistry 37, 3480-3490
15. Corbett, E. F., Oikawa, K., Francois, P., Tessier, D. C., Kay, C., Bergeron, J. J. M., Thomas, D. Y., Krause, K.-H., and Michalak, M. (1999) J. Biol. Chem. 274, 6203-6211
16. Dorner, A. J., Wasley, L. C., and Kaufman, R. J. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 7429-7432
17. Braakman, I., Helenius, J., and Helenius, A. (1992) Nature 356, 260-262
18. Dorner, A. J., and Kaufman, R. J. (1994) Biologicals 22, 103-112
19. Clairmont, C. A., De Maio, A., and Hirschberg, C. B. (1992) J. Biol. Chem. 267, 3983-3990
20. Berninsone, P., and Hirschberg, C. B. (1998) Ann. N. Y. Acad. Sci. 842, 91-99
21. Munro, S., and Pelham, H. R. D. (1986) Cell 46, 291-300
22. Flynn, G. C., Chappell, T. G., and Rothman, J. E. (1989) Science 245, 385-390
23. Wei, J., Gaut, J. R., and Hendershot, L. M. (1995) J. Biol. Chem. 270, 26677-26682
24. Wei, J., and Hendershot, L. M. (1995) J. Biol. Chem. 270, 26670-26676
25. Guthapfel, R., Gueguen, P., and Quemeneur, E. (1996) J. Biol. Chem. 271, 2663-2666
26. Michalak, M., Corbett, E. F., Mesaeli, N., Nakamura, K., and Opas, M. (1999) Biochem. J. 344, 281-292
27. Baksh, S., Spamer, C., Heilmann, C., and Michalak, M. (1995) FEBS Lett. 376, 53-57
28. Baksh, S., and Michalak, M. (1991) J. Biol. Chem. 266, 21458-21465
29. Saito, Y., Ihara, Y., Leach, M. R., Cohen-Doyle, M. F., and Williams, D. B. (1999) EMBO J. 18, 6718-6729
30. Ihara, Y., Cohen-Doyle, M. F., Saito, Y., and Williams, D. B. (1999) Mol. Cell 4, 331-341
31. Laemmli, U. K. (1970) Nature 227, 680-685
32. Towbin, H., Staehelin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354
33. Milner, R. E., Baksh, S., Shemanko, C., Carpenter, M. R., Smillie, L., Vance, J. E., Opas, M., and Michalak, M. (1991) J. Biol. Chem. 266, 7155-7165
34. Van Delden, C., Favre, C., Spat, A., Cerny, E., Krause, K.-H., and Lew, D. P. (1992) Biochem. J. 281, 651-656
35. Stendahl, O., Krause, K.-H., Krischer, J., Jerstrom, P., Theler, J. M., Clark, R. A., and Lew, D. P. (1994) Science 265, 1439-1441
36. Mery, L., Mesaeli, N., Michalak, M., Opas, M., Lew, D. P., and Krause, K.-H. (1996) J. Biol. Chem. 271, 9332-9339
37. Provencher, S. W., and Glöckner, J. (1981) Biochemistry 20, 33-37
38. Poch, E., Leach, S., Snape, S., Cacic, T., MacLennan, D. H., and Lytton, J. (1998) Am. J. Physiol. 275, C1449-C1458
39. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254
40. Matsudaira, P. (1987) J. Biol. Chem. 262, 10035-10038
41. Meldolesi, J., and Pozzan, T. (1998) Trends Biochem. Sci. 23, 10-14
42. Miyawaki, A., Llopis, J., Heim, R., McCaffery, J. M., Adams, J. A., and Ikura, M. (1997) Nature 388, 882-887
43. Bergmeyer, H.-U. (1965) Methods of Enzymatic Analysis , p. 999, Verlag Chemie, GmbH, New York
44. Burrell, M. M. (1993) Enzymes of Molecular Biology , Humana Press, Totowa, NJ
45. Vallee, B. L., and Falchuk, K. H. (1993) Physiol. Rev. 73, 79-118
46. Khanna, N. C., Tokuda, M., and Waisman, D. M. (1986) J. Biol. Chem. 261, 8883-8887
47. Kirchgessner, M., Wieninger-Rustemeyer, R., and Steinhart, H. (1980) Z. Tierphysiol. Tierernahr. Futtermittelkd. 43, 130-137
48. Furukawa, T., Fan, Z., Sawanobori, T., and Hiraoka, M. (1993) J. Physiol. (Lond.) 466, 707-726
49. Ou, W. J., Bergeron, J. J. M., Li, Y., Kang, C. Y., and Thomas, D. Y. (1995) J. Biol. Chem. 270, 18051-18059
50. Hendershot, L. M., Ting, J., and Lee, A. S. (1988) Mol. Cell. Biol. 8, 4250-4256
51. Leustek, T., Toledo, H., Brot, N., and Weissbach, H. (1991) Arch. Biochem. Biophys. 289, 256-261
52. Rindress, D., Lei, X., Ahluwalia, J. P., Cameron, P. H., Fazel, A., Posner, B. I., and Bergeron, J. J. M. (1993) J. Biol. Chem. 268, 5139-5147
53. Quemeneur, E., Guthapfel, R., and Gueguen, P. (1994) J. Biol. Chem. 269, 5485-5488
54. Cala, S. E., and Jones, L. R. (1994) J. Biol. Chem. 269, 5926-5931
55. Csermely, P., Miyata, Y., Schnaider, T., and Yahara, I. (1995) J. Biol. Chem. 270, 6381-6388
56. Chen, N. Q., Davis, A. T., Canbulat, E. C., Liu, Y. X., Goueli, S., McKenzie, B. A., Eccleston, E. D., Jr., Ahmed, K., and Holtzman, J. L. (1996) Biochemistry 35, 8299-8306
57. Cala, S. E. (1999) Biochem. Biophys. Res. Commun. 259, 233-238
58. Hirschberg, C. B., Robbins, P. W., and Abeijon, C. (1998) Annu. Rev. Biochem. 67, 49-69
59. Wearsch, P. A., and Nicchitta, C. V. (1997) J. Biol. Chem. 272, 5152-5156
60. Nigam, S. K., Goldberg, A. L., Ho, S., Rohde, M. F., Bush, K. T., and Sherman, M. (1994) J. Biol. Chem. 269, 1744-1749
61. Dierks, T., Volkmer, J., Schlenstedt, G., Jung, C., Sandholzer, U., Zachmann, K., Schlotterhose, P., Neifer, K., Schmidt, B., and Zimmermann, R. (1996) EMBO J. 15, 6931-6942
62. Frederickson, C. J., Perez-Clausell, J., and Danscher, G. (1987) J. Histochem. Cytochem. 35, 579-583
63. Holm, I. E., Andreasen, A., Danscher, G., Perez-Clausell, J., and Nielsen, H. (1988) Histochemistry 89, 289-293
64. Reddy, A. G., Devi, B. G., Rao, S. B., and Gupta, P. D. (1989) Cytobios 60, 21-26
65. Picello, E., Damiani, E., and Margreth, A. (1992) Biochem. Biophys. Res. Commun. 186, 659-667
66. Urade, R., Takenaka, Y., and Kito, M. (1993) J. Biol. Chem. 268, 22004-22009
67. Eggleton, P., Reid, K. B., Kishore, U., and Sontheimer, R. D. (1997) Lupus 6, 564-571
68. Eggleton, P., Ward, F. J., Johnson, S., Khamashta, M. A., Hughes, G. R. V., Hajela, V., Michalak, M., Corbett, E. F., Staines, N. A., and Reid, K. B. M. (2000) Clin. Exp. Immunol. 120, 384-391
69. Pike, S. E., Yao, L., Jones, K. D., Cherney, B., Appella, E., Sakaguchi, K., Nakhasi, H., Teruya-Feldstein, J., Wirth, P., Gupta, G., and Tosato, G. (1998) J. Exp. Med. 188, 2349-2356


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. E. Grespin, G. M. C. Bonamy, V. R. Roggero, N. G. Cameron, L. E. Adam, A. P. Atchison, V. M. Fratto, and L. A. Allison
Thyroid Hormone Receptor {alpha}1 Follows a Cooperative CRM1/Calreticulin-mediated Nuclear Export Pathway
J. Biol. Chem., September 12, 2008; 283(37): 25576 - 25588.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. B. Nanney, C. D. Woodrell, M. R. Greives, N. L. Cardwell, A. C. Pollins, T. A. Bancroft, A. Chesser, M. Michalak, M. Rahman, J. W. Siebert, et al.
Calreticulin Enhances Porcine Wound Repair by Diverse Biological Effects
Am. J. Pathol., September 1, 2008; 173(3): 610 - 630.
[Abstract] [Full Text]